BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/4/2025 7:57:04 AM | Browse: 209 | Download: 72
 |
Received |
|
2025-04-08 16:12 |
|
Peer-Review Started |
|
2025-04-08 16:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-25 09:34 |
|
Revised |
|
2025-05-06 12:05 |
|
Second Decision |
|
2025-07-07 02:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-07-07 08:17 |
|
Articles in Press |
|
2025-07-07 08:17 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-28 09:05 |
|
Publish the Manuscript Online |
|
2025-09-04 07:48 |
| ISSN |
2150-5349 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Therapeutic and preventive treatment on outcomes of hepatitis B virus induced chronic liver disease with a cost-effectiveness analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Wei Zhu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Shanghai |
No. 17ZR1431400 |
|
| Corresponding Author |
Wei Zhu, PhD, Post Doctoral Researcher, Shanghai Xi Rong Information Science and Technology Company Limited, National Science and Technology Park, School of Life Sciences and Technology, Tongji University, No. 1239 Siping Road, Yangpu District, Shanghai 200092, China. zhuwei8247@aliyun.com |
| Key Words |
Hepatitis B virus; Treatment; Outcome; Chronic liver disease; Cost-effectiveness |
| Core Tip |
Hepatitis B virus (HBV) infection remains the major obstacle in the management of chronic liver disease worldwide, despite vaccination and anti-viral therapy. The life cycle of HBV replication in hepatocytes has a critical role in the escape of virus under the management strategy. It is important to summarize the associated factors between the host and virus in the development of HBV-mediated chronic progression using a cost-effectiveness analysis. This mini-review highlights both vaccination and anti-viral therapy interruption of the associated stages of the HBV life cycle as well as the corresponding cost-effectiveness methods applied to evaluate the diagnostic strategies, vaccination and treatment in HBV management. |
| Publish Date |
2025-09-04 07:48 |
| Citation |
<p>Zhu W. Therapeutic and preventive treatment on outcomes of hepatitis B virus induced chronic liver disease with a cost-effectiveness analysis. <i>World J Gastrointest Pharmacol Ther</i> 2025; 16(3): 108190</p> |
| URL |
https://www.wjgnet.com/2150-5349/full/v16/i3/108190.htm |
| DOI |
https://dx.doi.org/10.4292/wjgpt.v16.i3.108190 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
